These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 77062)

  • 1. Modification of HLA antigens in patients with malignancies following hormone therapy.
    Májský A; Abrahámová J
    Tissue Antigens; 1978 Feb; 11(2):181-5. PubMed ID: 77062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy--one of the causes of transient loss of HLA antigens and lymphocyte polyreactivity in patients with blood diseases and malignancies.
    Májský A; Jakoubková J; Abrahámová J
    J Immunogenet; 1976 Dec; 3(6):429-33. PubMed ID: 796392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of absorption capacity of HLA antigens on in vitro hormone-treated lymphocytes.
    Májský A; Abrahámová J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(3):302-5. PubMed ID: 80356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal treatment of hypercalcemia caused by bone metastases.
    Muirhead W
    Can Med Assoc J; 1967 Sep; 97(11):569-72. PubMed ID: 6050889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modifications of lymphocyte HL-A antigens as a consequence of therapy in patients with manic-depressive psychosis].
    Májský A; Dvoráková M; Zvolský P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):509-17. PubMed ID: 83272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.
    Adair SJ; Carr TM; Fink MJ; Slingluff CL; Hogan KT
    J Immunother; 2008 Jan; 31(1):7-17. PubMed ID: 18157007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone therapy in cancer.
    Kennedy BJ
    Geriatrics; 1970 Oct; 25(10):106-12. PubMed ID: 4096937
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined chemo- and hormonal therapy in advanced breast cancer.
    Brunner KW; Sonntag RW; Alberto P; Senn HJ; Martz G; Obrecht P; Maurice P
    Cancer; 1977 Jun; 39(6 Suppl):2923-33. PubMed ID: 326385
    [No Abstract]   [Full Text] [Related]  

  • 9. Response of established human breast tumors to vaccination with mammaglobin-A cDNA.
    Narayanan K; Jaramillo A; Benshoff ND; Campbell LG; Fleming TP; Dietz JR; Mohanakumar T
    J Natl Cancer Inst; 2004 Sep; 96(18):1388-96. PubMed ID: 15367572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transient loss of HLA antigens on lymphocytes in patients following administration of penicillin and tetracyclin.
    Májský A; Todorovicová H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):502-5. PubMed ID: 83270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism.
    López de Castro JA; Strominger JL; Strong DM; Orr HT
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3813-7. PubMed ID: 6179086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal therapy of cancer of the female breast.
    Meakin JW
    Appl Ther; 1969 Feb; 11(2):84-7. PubMed ID: 5777753
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28.
    Dankers MK; Roelen DL; Van Der Meer-Prins EM; De Lange P; Korfage N; Smits JM; Persijn GG; Welsh KI; Doxiadis II; Claas FH
    Transplantation; 2003 Feb; 75(3):418-20. PubMed ID: 12589169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy in metastatic breast cancer: clinical response and urinary gonadotrophins.
    Stewart JG; Skinner LG; O'Connor PJ
    Acta Endocrinol (Copenh); 1965 Nov; 50(3):345-56. PubMed ID: 5898100
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of metastatic carcinoma of the female breast with combination of hormones and other chemotherapy.
    Firat D; Olshin S
    Cancer Chemother Rep; 1968 Dec; 52(7):743-50. PubMed ID: 5743711
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines.
    Travers PJ; Arklie JL; Trowsdale J; Patillo RA; Bodmer WF
    Natl Cancer Inst Monogr; 1982; 60():175-80. PubMed ID: 6181407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antigenic structure of HLA-A2: an analysis with competitive binding assays and monoclonal antibodies.
    Ways JP; Parham P
    J Immunol; 1983 Aug; 131(2):856-63. PubMed ID: 6190942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
    He X; Dong DD; Yie SM; Yang H; Cao M; Ye SR; Li K; Liu J; Chen J
    Ann Surg Oncol; 2010 May; 17(5):1459-69. PubMed ID: 20052552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive correlation between breast cancer incidence and HLA antigens.
    Bouillenne C; Deneufbourg JM
    Oncology; 1979; 36(4):156-9. PubMed ID: 471427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.
    Jaramillo A; Narayanan K; Campbell LG; Benshoff ND; Lybarger L; Hansen TH; Fleming TP; Dietz JR; Mohanakumar T
    Breast Cancer Res Treat; 2004 Nov; 88(1):29-41. PubMed ID: 15538043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.